Chrystyna Bedrij Stecyk - 11 May 2023 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Director
Signature
/s/ Scott E. Royer, Attorney-in-Fact for Chrystyna Bedrij Stecyk
Issuer symbol
VCNX
Transactions as of
11 May 2023
Net transactions value
$0
Form type
4
Filing time
15 May 2023, 16:33:01 UTC
Previous filing
13 May 2022
Next filing
14 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +143,848 $0.000000 143,848 11 May 2023 Common Stock 143,848 $0.4100 Direct F4
holding VCNX Stock Option (Right to Buy) 25,087 11 May 2023 Common Stock 25,087 $3.95 Direct F1
holding VCNX Stock Option (Right to Buy) 28,586 11 May 2023 Common Stock 28,586 $2.15 Direct F2
holding VCNX Stock Option (Right to Buy) 53,254 11 May 2023 Common Stock 53,254 $1.12 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
F2 This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
F3 This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
F4 This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.